Medical Microneedle Diagnostics


prefillable biological drug delivery  Medical Microneedle Diagnostics • MDG592F • January 2022 • US$3,850


 

 

Microneedle technology is attaining commercial viability at a time when healthcare providers are faced with new challenges as they assess ways to incorporate companion diagnostics into their practice areas. Microneedle technology has the potential to address the growing trend toward point of care diagnostics and ambulatory patient monitoring by allowing the precise detection of biomarkers and analytes in fluids and tissues located below the skin. To succeed, developers must refine the techniques available and in development for sampling very small quantities and/or concentrations of analytes and biomarkers and advance the design integration of microneedles into commercially viable diagnostic platform.

 

 
 
 
 
 
          Order Online HERE
 
 

Prefillable Biological Drug Delivery – What You Will Learn

  • What companies are active in the microneedle diagnostics segments, what distinguishes their technology, and what is their market presence?
  • Who are the microneedle diagnostic device developers/suppliers, and what are their capabilities?
  • What are the major factors that are influencing demand for microneedle diagnostics?
  • What are the essential design factors, material selection issues, technologies and market development issues for diagnostic microneedle products?
  • What are the important healthcare markets for microneedle diagnostics? What is their market potential? 
  • What are the significant economic, technology, and regulatory factors affecting the market for diagnostic microneedles?
  •  

 

Summary of Contents

Executive Summary
The Market Opportunity
Point-of-Care Diagnostics Market Dynamics
Microneedle Product Categories
Solid Microneedles
Hollow Microneedles
Coated Microneedles
Dissolving Microneedles
Stretched Needles
Carbon Nanotubes
Ion Etching
C-MEMS
Specialty Microneedles
Phase Transition
Microprocessor-based Devices
Composite Microneedles
Light-responsive Microneedles
Flexible Arrays
Microneedle Arrays & Array Geometries
Array Architectures
Microneedles & Microfluidics
Wearable Microneedles
What’s Driving the Growth in PoC Diagnostics?
Shifting Patient Demographics
Disease and Condition Demand Drivers
Patient Self-care
The Role of Interstitial Fluid
Microneedle Diagnostics – Design Factors
Analyte Capture
Sample Acquisition
Biofluid Absorption
Electrochemical Sensing
Materials Selection
Sensor Array Integration
Microneedle Fabrication
Micromolding
Microforming
Micromachining
Structured Films

Emerging Fabrication Methods
3D Printing
Electrospun Arrays
Two-Photon Polymerization (2PP)
Magnetization-induced Self-assembly
Additive Fabrication Methods
Stereolithography
Fused Deposition Modelling
Digital Light Processing
Selective Laser Sintering
Selective Laser Melting
Inkjet Printing
Surface Modification
Diagnostic Microneedle Device Analysis
Micro Transdermal Interface Platform (MicroTIPs)
Mindera Health
Scibase (Nevisense)
Seventh Sense Biosystems
Sysmex
Microneedle Diagnostics – Key Therapeutic Sectors
Diabetes
Glucose
Immunology
Immune Factors
Infectious Disease
Tuberculosis
Metabolic
Electrolytes/Potassium
Oncology
Biomarker-enabled Diagnostics
Squamous Cell Carcinoma
Orthopedics
Osteoarthritis
Government and Academic Programs
Market Factors
Patient Compliance and Ease of Use
Patient Safety and Compliance
Healthcare Economics
Company Profiles
Market Participant Profiles